Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (3494)	11/5/2002 8:21:06 AM
From: Icebrg	Read Replies (1) of 10345

Harold, That is correct. Dr. Tracy suggested the following explanation about a year ago in a CNS regeneration review. Erik >>The sonic hedgehog program had been partnered with Biogen, but in mid-2000, Biogen suddenly surrendered its interest, returning the rights to Curis. This usually means either research failure or a retooling of corporate priorities. In this case, what we have heard was that Biogen's R&D group liked the sonic hedgehog program, but Biogen management did not like the fact that Biogen's ex-CEO James Tobin was a member of the new Curis Board, and chose to sever ties.>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next